跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Authorized
STANDARD
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
156de2c4ea35bcc2
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
156de2c4ea35bcc2
Drug Approval Canada Name
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Product Name
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Status
Marketed
Status Date
2023-02-01
Original Market Date
2023-02-01
Din
02534258
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.05
Atc Original
A10BD07 METFORMIN AND SITAGLIPTIN
Atc Name
a 10 bd 07
Aig Number
0252656003
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
METFORMIN HYDROCHLORIDE
1000 MG
SITAGLIPTIN (SITAGLIPTIN MALATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
156de2c4ea35bcc2
Type
Standard
Back to Health Canada Approvals
